Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0017636 (glioblastoma)
 18,345 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

An observation of cerebral glioblastoma transformed from dedifferentiated astrocytoma with metastasis into cervical and lumbar lymph nodes is presented. Growth of the tumour into the area of scars in dura mater formed after repeated operations for the tumour removal contributed to metastasizing.
 ...
PMID:[Brain glioblastoma with metastases into the cervical and lumbar lymph nodes]. 51 68

In order to establish the standard of administration of ACNU against brain tumors, pharmacokinetic analysis of ACNU in tumor tissue, cystic fluid, cerebrospinal fluid and blood was performed. The sample specimens were obtained sequentially after intravenous administration of 1--2 mg/kg/BW of ACNU and quantitatively analysed by high-performance liquid chromatography in 3 cases of glioblastoma and each one case of astrocytoma, meningioma and brain metastasis. Concentrations of ACNU in blood was calculated by two compartment open model and those in cystic fluid was calculated by one compartment model using BMDP-3R program. The half-time in blood was 2.6--4.1 min, and its distribution was very fast. The penetration of ACNU into the tumor tissue was sufficient, because the central compartment was 23% and the tissue compartment was 77%. The transmission rate constant into the cyst was 1.8 and the elimination rate constant was 0.96. The maximum concentration in the cystic fluid 42 min after intravenous injection of 2 mg/kg/BW of ACNU was 0.27--0. 35 mg/dl. In conclusion, 3--4 mg/kg/BW of ACNU should be injected intravenously at one time.
 ...
PMID:[Pharmacokinetic analysis of ACNU in brain tumors (author's transl)]. 52 72

Thirteen patients with intracranial lesions were submitted to a twist drill needle biopsy under computerized tomographic (CT) control, with sedation and local anesthesia. (The patients' ages ranged from 12 to 81 years.) The final diagnoses were glioblastoma in 7 patients and 1 case each of anaplastic astrocytoma, low grade astrocytoma, thrombosed arteriovenous malformation, cerebral infarct, 3rd ventricular epidermoid, and degenerative disease of the brain. Definitive diagnosis was obtained in all but 2 patients with this technique. Appropriate therapy was subsequently instituted in 11 patients without further operation. Transiently increased weakness of the previously affected limbs was the only untoward effect (4 patients). Intracranial hematoma after this procedure was seen in 1 patient in this series, as detected by the postprocedure CT scan, but there was no change in the clinical course. All patients were treated with dexamethasone for 24 to 48 hours before and for several days after the procedure to avoid decompensation of intracranial dynamics because of edema. The procedure, including appropriate level CT scans of the lesion area, was performed in approximately 1 hour in all patients. (Neurosurgery, 5: 671--674, 1979).
 ...
PMID:Needle biopsy under computerized tomographic control: a method for tissue diagnosis in intracranial lesions. 53 75

Immunoelectrophoresis of extracts of 200 intracranial tumours against rabbit anti-glioblastoma serum gave positive results (= precipitation) in all cases of tumours of neuroectodermal origin such as glioblastoma, astrocytoma, oligodendroglioma, ependymoma, neurinoma, and spongioblastoma. No immunoelectrophoretic precipitation was seen for any of the tumours of mesenchymal origin, for instance meningioma and metastases of cancer. On the basis of these findings, immunoelectrophoresis is considered to be a reliable method for differentiation between tumour tissue of neuroectodermal and non-neuroectodermal origin. Among the 41 posterior fossa tumours some unusual observations were made. Cerebellar angioblastoma (Lindau tumour) showed an atypically located precipitation line, which for the present is interpreted as an immunological reaction to vascular wall tissue. Furthermore, among the group of so-called medulloblastomas, two subgroups were distinguished on the basis of three parameters. The first of these subgroups comprises tumours whose immunoelectrophoretic pattern resembles that of gliomas, which are histologically characterized by neuroectodermal structures and which occur in younger children (5--10 years). The tumours of the second subgroup, which do not show this neuroectodermal immunoelectrophoretic pattern, have a sarcomatous character histologically, and occur in patients aged between 10 and 50 years. The view that medulloblastoma comprises a number of different types of tumour seems to be confirmed by this finding.
 ...
PMID:Immunoelectrophoresis in the diagnosis of neuroectodermal and mesodermal intracranial tumours, especially those of the posterior fossa. 57 8

The CT patterns of 295 glioblastomas examined with pre- and postcontrast scans using an EMI scanner Mark I (Matrix 160/160) have been reviewed and compared with the CT appearances of other brain tumors, metastases and abscesses. There is a great variety of CT patterns with glioblastomas. However, a garland-shaped CT appearance, representing a subgroup of ring-shaped lesions, seems to be most typical for glioblastomas since it was observed in 19% of ring-shaped glioblastomas but in only one out of 172 metastases and in no case of an astrocytoma grade II or an abscess in our series. The initial CT diagnosis, based on the CT finding, the patient's history and the clinical data, was correct in 69.8% of the glioblastomas, 41 recurrent glioblastomas included. In 12% of the cases the presence of a glioblastoma was within differential diagnosis. These results lead to the conclusion that in many cases additional diagnostic methods, such as serial scintigraphy and/or cerebral angiography, are required for a reliable differential diagnosis.
 ...
PMID:Computed tomography in the diagnosis and differential diagnosis of glioblastomas. A qualitative study of 295 cases. 60 Mar 82

A number of cases of multiple primary intracranial neoplasms have been reported, including tumors of neuroepithelial and mesenchymal origin. The presence of meniogioma has been reported in association with glioblastoma, oligodendroglioma, astrocytoma, and eosinophilic adenoma. This case represents a unique example of adjacent chromophobe adenoma and meningioma. The usefulness of computed tomography in the diagnosis of concomitant lesions with different density attenuations is discussed.
 ...
PMID:Case report. Tandem lesions: chromophobe adenoma and meningioma. 61 35

Surface membrane microprojections and coated vesicles of a well differentiated (Kernohan-Sayre grade I) cerebral fibrillary astrocytoma were compared with those of anaplastic astrocytic (grade IV, glioblastoma) cerebral tumors. Both phenomena increase with increased malignancy. This provides further evidence for membrane alterations with malignant change in human astrocytic cells. It is the first comparison of fibrillary astrocytoma surface phenomena with those of more malignant astrocytic tumors of the cerebrum.
 ...
PMID:Frequency of surface microprojections and coated vesicles with increased malignancy in human astrocytic neoplasms. 71 44

Sera from patients with malignant and benign gliomas, as well as sera from healthy donors, were tested by indirect immunofluorescence to detect antibodies against antigens on the membrane of glioblastoma, astrocytoma, reactive perimetastatic glia, normal glia and fibroblasts in tissue culture. Sera from glioblastoma patients reacted with glioblastoma, astrocytoma and reactive glial cells; they were negative on normal glia and on fibroblasts, whereas sera from astrocytoma patients were unreactive. Sera from control patients were positive in 7 out of 15 cases, although some differences were noted in the pattern of reaction. Absorption with astrocytoma powder, with glioblastoma and reactive glial cells indicated that all the positive cell lines expressed an astrocytoma-associated antigen "A", while only glioblastoma lines and reactive glial line shared a supplementary antigen "G". Neither of these 2 antigens seemed to be present in significant amount in normal brain, since the positive reactions could not be abolished by absorption with normal brain powder. The relationship between these 2 antigens and the process of increasing malignancy in gliomas is briefly discussed.
 ...
PMID:Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence. 78 26

The authors present a retrospective study of 670 histologically verified tumours of the neuraxis collected over 90 months in the Neurological Hospital, Lyons. The main facts concerning histological type, topography of the tumour, date of diagnosis, address, profession, O.B.O. and Rhesus groups, age and sex were codified for feeding into a computer and processed by sophisticated statistical methods. This analysis shows the homogeneity of topographical distribution in the brain of the different types of glioma, the special genetic code of meningiomas (predominance of A and B genes of the A.B.O. group), absence of the same factors for glioblastoma. Sex ratio analysis shows the contrast between definitely masculine tumours--glioblastomas and astrocytomas--and meningiomas and spongioblastomas. Analysis of the "age specific rate" separates tumours prevalent in the young, where incidence is a decreasing function of age (spongioblastoma, medulloblastoma, cerebellar astrocytoma) and tumours prevalent in adults which are mainly meningiomas and glioblastomas whose incidence is an increasing exponential function of age. Epidemiological analysis shows the difference in geographical distribution of glioblastomas and meningiomas. As far as glioblastomas are concerned, it would appear that on to the general rule of constant tumourincidence over the area as a whole, is superimposed another of high incidence in particular districts of the Beaujolais and Maconnais regions. The aetiological implications of these various findings are discussed.
 ...
PMID:[Epidemiological study of primary tumors of the neuraxis in the Rhone-Alps region. Quantitative data on the etiology and geographical distribution of 1670 tumors]. 122 81

In view of the fact that clinical reports have been recently made that combined varopressin-corticosteroid therapy is remarkably effective against recurrent malignant astrocytoma, it is considered necessary to review the antitimor action of steroids against glioma. The effects of hydrocortisone sodium succinate were studied on cultured cells derived from 17 glioma cases composed of 8 cases of glioblastoma (grade III, IV) and 9 cases of benign astrocytoma (grade I, II). Actively growing monolayer culture of tumor cells was exposed to the test agent of serially diluted concentration from 10(-4) to 10(-7) g/ml. The effectiveness was estimated by calculating the proliferation rate of cells for 7 days. The response curve of the test agent exhibited a relatively good correlation to dose as well as a good potency in suppressing cellular proliferation. This was more marked in cells from malignant glioma than those from benign glioma. The results also indicate that the inhibitory effects of corticosteroid are closely correlated to the growth rate of the tumor itself. Thus, the therapeutic effects of long-term administration of corticosteroid can be expected not only by the resultant decrease in cerebral edema and in the suppressed production rate of cerebrospinal fluid but also from the standpoint of its anti-timor action. It should be possible to effectively include steroid therapy in the program of surgical procedure, radiation therapy and chemotherapy for glioma patients in whom recurrence is generally almost inevitable.
 ...
PMID:[The inhibitory effects of corticosteroid on the proliferation of tumor cells derived from human astrocytoma-gliobastoma--with special reference to combined vasopressin--corticosteroid therapy (author's transl)]. 123 14


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>